NGS-based liquid biopsy lab-developed test that analyzes cfDNA, cfRNA and MSI from one standard tube of blood to deliver full genomic-load results within one week. Somatic and germline profiling from blood, tissue and buccal samples (DNA, RNA, MSI, PD-L1) to support clinicians in selecting targeted therapies and monitoring treatment efficacy and recurrence.